geared toward Doctors Foster and Smith Chlorhexidine Cloth Generic Name: chlorhexidine cloth Dosage Form: FOR ANIMAL USE ONLY Print this page Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. DIRECTIONS Clean affected area thoroughly. Apply pad to affected area 2 to 3 times daily or as directed by your veterinarian. Let product dry, then area may be covered or bandaged. CAUTION For external use only. Avoid contact with eyes. Consult your veterinarian in cases of deep or puncture wounds, animal bites, serious burns or if redness and irritation persists or increases. ACTIVE INGREDIENT 0.5% Chlorhexidine Diacetate OTHER INGREDIENTS Aloe Vera Gel, Bitter Extractives, Boric Acid, Fragrance, Glycerin, Isopropyl Alcohol, Propylene Glycol, Water. STORAGE Keep tightly closed at room temperature. For animal use only. Keep out of reach of children and pets to prevent accidental ingestion. Doctors Foster and Smith Veterinarian Formulated Septi-Soothe Pads Gentle, Antiseptic Formula 90 Pads DOCTORS FOSTER AND SMITH chlorhexidine cloth Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:65713-908 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CHLORHEXIDINE (CHLORHEXIDINE) CHLORHEXIDINE 0.052 g in 104 g Inactive Ingredients Ingredient Name Strength ALOE VERA LEAF BORIC ACID GLYCERIN ISOPROPYL ALCOHOL PROPYLENE GLYCOL WATER Packaging # Item Code Package Description 1 NDC:65713-908-05 104 g in 1 JAR Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2000 Labeler - Doctors Foster and Smith (122135148) Registrant - United Pet Group (931135730) Establishment Name Address ID/FEI Operations JUNGLE LABORATORIES CORPORATION 032615270 manufacture Revised: 03/2010 Doctors Foster and Smith FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More chase away
brilliant Doctors Foster and Smith Chlorhexidine Cloth rewarding
EmoticonEmoticon